Related content

Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials

By Hung H. M. James  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1201-1210

Taylor & Francis Ltd

Access to resources Recommend Favorite

Multiple Comparisons of Repeatedly Measured Response: Issues of Validation Testing in Thorough QT/QTc Clinical Trials

By Tsong Yi   Yan Lihan   Zhong Jinglin   Nie Lei   Zhang Joanne  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 3, 2010-05 ,pp. : 654-664

Taylor & Francis Ltd

Access to resources Recommend Favorite

Power Comparisons for Group Sequential Tests with Nonparametric Statistics in Case of Nonproportional Hazards

By Demirhan Haydar  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 447-460

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Re-Estimation for Adaptive Sequential Design in Clinical Trials

By Gao Ping  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 6, 2008-11 ,pp. : 1184-1196

Taylor & Francis Ltd

Access to resources Recommend Favorite

Adaptive Group Sequential Test for Clinical Trials with Changing Patient Population

By Feng Huaibao  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1227-1238

Taylor & Francis Ltd

Access to resources Recommend Favorite